This work provides for the first time a complex insight into the mechanism of radiosensitization of the p53-deficient model cell line (HL-60, human promyelocytic leukemia) by the highly specific ATR inhibitor, VE-821. This evidence concerns the gene ATR and acute promyelocytic leukemia.